|
Index of reports
> Cases with Acute Myeloid Leukaemia ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include acute myeloid leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Herceptin side effects in female
Reported by a physician from France on 2012-06-22
Patient: female
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Herceptin
Start date: 2008-05-19
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2008-04-28
End date: 2008-04-28
Possible Herceptin side effects in 67 year old female
Reported by a individual with unspecified qualification from Japan on 2012-06-22
Patient: 67 year old female
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: cumulative dose
Herceptin
Dosage: 18 time administering
Indication: Breast Cancer
UFT
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Colon Cancer
Other drugs received by patient: Fluorouracil; Docetaxel; Cyclophosphamide; Cyclophosphamide; Fluorouracil; Epirubicin Hydrochloride; Epirubicin Hydrochloride
Possible Herceptin side effects in female
Reported by a physician from France on 2012-06-15
Patient: female
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2008-04-28
End date: 2008-04-28
Herceptin
Start date: 2008-05-19
Possible Herceptin side effects in 67 year old female
Reported by a individual with unspecified qualification from Japan on 2012-06-11
Patient: 67 year old female
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Fluorouracil
Dosage: one course
Indication: Breast Cancer
Herceptin
Dosage: 18 time administering
Indication: Breast Cancer
Docetaxel
Dosage: four courses
Indication: Breast Cancer
Epirubicin Hydrochloride
Dosage: three courses
Epirubicin Hydrochloride
Dosage: one course
Indication: Breast Cancer
Fluorouracil
Dosage: three courses
Cyclophosphamide
Dosage: three courses
Cyclophosphamide
Dosage: one course
Indication: Breast Cancer
Possible Herceptin side effects in 67 year old female
Reported by a pharmacist from Japan on 2012-06-11
Patient: 67 year old female
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Fluorouracil
Dosage: three courses
Epirubicin Hydrochloride
Dosage: three courses
Herceptin
Dosage: 18 time administering
Indication: Breast Cancer
Epirubicin Hydrochloride
Dosage: one course
Indication: Breast Cancer
Cyclophosphamide
Dosage: one course
Indication: Breast Cancer
Docetaxel
Dosage: four courses
Indication: Breast Cancer
Fluorouracil
Dosage: one course
Indication: Breast Cancer
Cyclophosphamide
Dosage: three courses
Possible Herceptin side effects in female
Reported by a physician from France on 2012-05-09
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Chromosomal Mutation, Acute Myeloid Leukaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Taxotere
Indication: Breast Cancer
Start date: 2009-06-02
End date: 2009-07-15
Fluorouracil
Indication: Breast Cancer
Start date: 2009-03-31
End date: 2009-05-12
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2009-03-31
End date: 2009-05-12
Herceptin
Indication: Breast Cancer
Start date: 2009-06-02
End date: 2009-11-12
Cyclophosphamide
Indication: Breast Cancer
Start date: 2009-03-31
End date: 2009-05-12
Other drugs received by patient: Tamoxifen Citrate
Possible Herceptin side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08
Patient: 54 year old female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Paclitaxel
Indication: Breast Cancer Stage III
Cyclophosphamide
Indication: Breast Cancer Stage III
Doxorubicin HCL
Indication: Breast Cancer Stage III
Herceptin
Indication: Breast Cancer Stage III
Possible Herceptin side effects in female
Reported by a physician from France on 2012-03-30
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Chromosomal Mutation, Acute Myeloid Leukaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Start date: 2009-06-02
End date: 2009-11-12
Taxotere
Indication: Breast Cancer
Start date: 2009-06-02
End date: 2009-07-15
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2009-03-31
End date: 2009-05-12
Cyclophosphamide
Indication: Breast Cancer
Start date: 2009-03-31
End date: 2009-05-12
Fluorouracil
Indication: Breast Cancer
Start date: 2009-03-31
End date: 2009-05-12
Other drugs received by patient: Tamoxifen Citrate
Possible Herceptin side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-01
Patient: male
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Fluorouracil
Indication: Gastric Cancer
Start date: 2010-11-11
End date: 2011-02-28
Herceptin
Indication: Gastric Cancer
Start date: 2010-11-10
End date: 2011-08-03
Oxaliplatin
Indication: Gastric Cancer
Start date: 2010-11-11
End date: 2011-02-28
Possible Herceptin side effects in 43 year old female
Reported by a physician from Japan on 2011-10-24
Patient: 43 year old female
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Breast Cancer Metastatic
Herceptin
Indication: Breast Cancer Metastatic
Other drugs received by patient: Vinorelbine Tartrate; Tykerb
|
